ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mendeloff, E. N.
Right arrow Articles by Clark, R. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mendeloff, E. N.
Right arrow Articles by Clark, R. E.

The Annals of Thoracic Surgery, Vol 57, 999-1006, Copyright © 1994 by The Society of Thoracic Surgeons


ARTICLES

Thromboxane A2 receptor-specific antagonism in hypothermic cardiopulmonary bypass

EN Mendeloff, IY Liang, JA Swain and RE Clark
Surgery Branch, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD.

Using a thromboxane A2 receptor-specific antagonist, SQ 30,741, this study was undertaken to define the role of thromboxane A2 in postischemic myocardial reperfusion injury and in the heparin-protamine reaction. Eighteen heparinized (300 units/kg) sheep were placed on cardiopulmonary bypass (CPB) after complete instrumentation, cooled to 28 degrees C, and had their aortas crossclamped for 1 hour. They were then rewarmed to 36 degrees C and weaned from CPB without inotropic support. Control sheep (n = 6) received a saline infusion throughout the procedure. Bolus animals (n = 6) received 5 mg/kg of SQ 30,741 at 5 minutes after discontinuation of CPB and before protamine sulfate administration. Infusion animals (n = 6) received an SQ 30,741 bolus of 5 mg/kg followed by a continuous infusion of 5 mg.kg-1 hr-1 of SQ 30,741 initiated before CPB. All animals received 5 mg/kg of protamine sulfate over a 15-second period 15 minutes after being weaned from CPB. Control animals exhibited significantly decreased global myocardial function after the 1-hour ischemic interval. Further significant functional decline and increase in pulmonary pressure occurred after protamine sulfate administration. Bolus animals experienced a similar postischemic injury, but had no further decrease in function following protamine infusion. Infusion animals had significantly improved global myocardial function after bypass compared with both other groups and were also protected from the deleterious effects of protamine sulfate administration.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
ChestHome page
R. Gerrah, A. Elami, A. Stamler, A. Smirnov, and Z. Stoeger
Preoperative Aspirin Administration Improves Oxygenation in Patients Undergoing Coronary Artery Bypass Grafting
Chest, May 1, 2005; 127(5): 1622 - 1626.
[Abstract] [Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
H. A. Hennein
Inflammation After Cardiopulmonary Bypass: Therapy for the Postpump Syndrome
Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2001; 5(3): 236 - 255.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
L. J. Dacey, J. J. Munoz, E. R. Johnson, B. J. Leavitt, C. T. Maloney, J. R. Morton, E. M. Olmstead, J. D. Birkmeyer, and G. T. O'Connor
Effect of preoperative aspirin use on mortality in coronary artery bypass grafting patients
Ann. Thorac. Surg., December 1, 2000; 70(6): 1986 - 1990.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
T. Nakajima, K. Kawazoe, K. Ishibashi, Y. Kubota, T. Sasaki, H. Izumoto, and T. Nitatori
Reduction of heparin dose is not beneficial to platelet function
Ann. Thorac. Surg., July 1, 2000; 70(1): 186 - 190.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
S. Fehmi Katircioglu, T. Ulus, B. Yamak, Z. Saritas, and U. Yildiz
Experimental Inhibition of Protamine Cardiotoxicity by Prostacyclin
Angiology, November 1, 1999; 50(11): 929 - 935.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
S. F. Katircioglu, D. S. Kucukaksu, O. Tasdemir, K. Bayazit, R. E. Clark, E. N. Mendeloff, I. Y.S. Liang, and J. A. Swain
Arachidonic Acid Metabolism After Heparin Reversal With Protamine
Ann. Thorac. Surg., February 1, 1995; 59(2): 550 - 551.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1994 by The Society of Thoracic Surgeons.